We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

353 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 112 increasing their positions, 119 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 43

4% more funds holding

Funds holding: 339 → 353 (+14)

6% less repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 119

11% less capital invested

Capital invested by funds: $6.45B → $5.72B (-$735M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

35% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $120M

Holders
353
Holders Change
+14
Holders Change %
+4.13%
% of All Funds
9.51%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
58
Increased
112
Reduced
119
Closed
43
Calls
$78.8M
Puts
$120M
Net Calls
-$41.7M
Net Calls Change
-$37.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$36.1M
2
CS
Credit Suisse
Switzerland
+$30.3M
3
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
+$29.1M
4
First Trust Advisors
First Trust Advisors
Illinois
+$25M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$24.7M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$126M
2
BA
BlackRock Advisors
Delaware
-$50.1M
3
EAM
Eagle Asset Management
Florida
-$46.5M
4
State Street
State Street
Massachusetts
-$42.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$42.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
376
Brown Advisory
Maryland
– -$361K -5,665 Closed
EA
377
Emerald Advisers
Pennsylvania
– -$321K -5,337 Closed
QI
378
Quotient Investors
New York
– -$318K -5,000 Closed
MSU
379
Maple Securities USA
New Jersey
– -$317K -4,974 Closed
Allianz Asset Management
380
Allianz Asset Management
Germany
– -$306K -4,805 Closed
NI
381
Numeric Investors
Massachusetts
– -$261K -4,100 Closed
TU
382
TDAM USA
Ontario, Canada
– -$259K -4,068 Closed
TI
383
Turner Investments
Pennsylvania
– -$248K -3,900 Closed
FAM
384
Fortaleza Asset Management
Illinois
– -$226K -3,555 Closed
UR
385
USCA RIA
Texas
– -$223K -3,500 Closed
JIP
386
Jaffetilchin Investment Partners
Florida
– -$219K -3,447 Closed
WAM
387
World Asset Management
Michigan
– -$219K -3,443 Closed
AF
388
Aldebaran Financial
– -$210K -3,300 Closed
PCM
389
Price Capital Management
Louisiana
– -$210K -3,300 Closed
MMG
390
Monetary Management Group
Missouri
– -$178K -2,800 Closed
TNB
391
Thomasville National Bank
Georgia
– -$10K -150 Closed
SAM
392
Shamrock Asset Management
Texas
– -$6K -100 Closed
GWM
393
Gupta Wealth Management
California
– -$3K -45 Closed
WCM
394
Wealthcare Capital Management
Virginia
– -$1K -20 Closed
ZB
395
Zions Bancorporation
Utah
– -$1K -17 Closed
ASN
396
Advisory Services Network
Georgia
– +$445 +7 New
12 13 14 15
16

IONS Hedge Fund Activity: Q2 2015 in Review

353 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2015, worth a combined $5.72B — down 11% from $6.45B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new IONS positions and 43 closed out — a net gain of 15 holders — while 112 added to existing stakes and 119 trimmed.

The largest buyer was Vanguard Group, adding an estimated $36.1M. The largest seller was BlackRock Fund Advisors, cutting an estimated $126M.

  • 353 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2015, up from 339 in Q1 2015.
  • Funds reported $5.72B of Ionis Pharmaceuticals stock for Q2 2015, down 11% quarter-over-quarter.
  • 58 funds opened new Ionis Pharmaceuticals positions in Q2 2015 and 43 closed out, a net change of +15 holders.
  • The largest Ionis Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $36.1M added.
  • The largest Ionis Pharmaceuticals seller in Q2 2015 was BlackRock Fund Advisors, an estimated $126M sold.

Based on aggregated 13F filings for Q2 2015.